SMITH SCOTT THOMAS (EVP & Chief Financial Officer) purchased 2.3% of their position (100.00 shares) of ASCENDIS PHARMA A/S on the open market
Open‑market purchase worth $21.9K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/2/2026ACC: 0001610717-26-000179
Officer· EVP & Chief Financial Officer
Since Mar 2026
+100.00
Net shares
Net buyer
$21.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100.00 acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+100.00
Price / share
$219.00
Trade value
$21.90K
% of position
2.3%
6/2/2026
4.27K→4.37K
Total
Net shares
+100.00
Net value
$21.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/2/2026 | P · Purchase | +100.00 | $219.00 | $21.90K | 2.3% | 4.27K | 4.37K |
| Total | +100.00 | $21.90K | ||||||
Derivative Transactions0
No derivative transactions reported